In order to view the full papers, click on the titles highlighted in blue. 
The papers are in .rtf format (Rich Text Format).

SATURDAY SEPTEMBER 8TH
08:30-10:00	DIAGNOSIS AND SURGICAL PROCEDURES Chair: V. Gomel, A. DeCherney, O. Gokmen	HALL A
	Capsule: With many old and innovative solutions, confusion over procedure selection exists.
	HSG VS HYSTEROSCOPY VS HYDROSONOGRAPHY F.M. Severi, Italy
	LAPAROSCOPY VS MINILAPAROSCOPY VS. TRANS-VAGINAL HYDRO-LAPAROSCOPY H. Verhoeven, Germany
	MYOMECTOMY - ITS ROLE IN INFERTILITY J. Dubuisson, France
	HYDROSALPINGX - TO TREAT OR NOT? A. Strandell, Sweden
	INTRAMURAL FIBROIDS. MYOMECTOMY OR ART? WHICH COMES FIRST? S. Mashiach, Israel
10:30-12:30	Session sponsored by NV ORGANON
	CONTRACEPTION: CONNECTIONS AND DISCONNECTIONS BETWEEN WOMEN AND DOCTORS Chair: J. Bitzer, H. Rekers
	INTRODUCTION  J. Bitzer, Switzerland
	THE IMPORTANCE OF SKIN CONDITION FOR YOUNG WOMEN AND CLINICIANS  S. Van der Doef, The Netherlands
	ANATOMY AND PHYSIOLOGY OF THE SKIN  B. Tebbe, Germany
	CLINICAL PROFILES OF ORAL CONTRACEPTIVES M. Vree, The Netherlands
12:30-14:30	Lunch session sponsored by ORTHO-MCNEIL PHARMACEUTICALS
	THE HORMONAL CONTINUUM BENEFITS TO WOMEN FROM MENARCHE TO MENOPAUSE Chair: J. Mattox
	RATIONALE FOR PULSED NORGESTIMATE HRT R. Casper, Canada
	NORGESTIMATE AND NEW TRENDS IN HRT - RESPONSES TO CHALLENGES OF MID-LIFE WOMEN J. Mattox, USA
14:30-16:00	OVULATION INDUCTION AND INSEMINATION Chair: R.Casper, L. Hamberger, N. Gleicher
	Capsule: With increase indication for IVF, maximizing the success rate before IVF is the goal.
	SHOULD TREATMENT WITH CLOMIPHENE CITRATE CONTINUE? H. J. Out, UK
	IS IUI MANDATORY BEFORE IVF? NATURAL VS. STIMULATED CYCLE P. Crosignani, Italy
	INTRA-CERVICAL, UTERINE OR TUBAL - WHAT IS THE EVIDENCE? P. Barri, Spain
	FORGET ABOUT OVULATION INDUCTION! PROCEED DIRECTLY TO IVF!! N. Gleicher, USA
	WHEN SHOULD WE PROCEED TO IVF AND ICSI? M. Germond, Switzerland
16:30-18:30	IVF - CAN WE INCREASE THE SUCCESS RATE? Chair: B. Tarlatzis, C. Chillik, J. Mandelbaum
	Capsule: Despite technology improvements, the question remains.
	CAN WE IMPROVE THE EMBRYO QUALITY? BIOLOGIST'S ROLE, CLINICIAN'S ROLE  M.J. Torello, Spain M. Germond, Switzerland
	CAN WE IMPROVE ENDOMETRIAL RECEPTIVITY? A. Pellicer, Spain
	ASSISTED HATCHING - IS IT A SERIOUS ALTERNATIVE? N. Laufer, Israel
	GUIDED ET? D. Gardner, USA
	BLASTOCYSTS VS. DAY 2-3 ET - HOW STRONG IS THE EVIDENCE? D. Gardner, USA
08:30-10:00	Endorsed by the Tarnesby chair of fertility regulation
	BIRTH CONTROL  Chair: David Serfaty, G.K. Creatsas, S. Segal	HALL B
	Capsule: Oral contraception is most commonly used. Are there any limitations?
	OCS - VERY LOW ESTROGEN DOSAGES: PROS AND CONS G. Creatsas, Greece
	EMERGENCY CONTRACEPTION - OTC? FREE OF CHARGE? PROS AND CONS D. Serfaty, France
	OCS - OTC? PROS AND CONS A. Yeshaya, Israel
	ORAL CONTRACEPTION IN A PATIENT WITH A FIRST DEGREE RELATIVE WITH BREAST CANCER P. Spinola, Brazil
10:30-12:30	MENOPAUSAL HEALTH - TREATMENT Chair: W. Utian, M. Lachowsky, A. Volpe
	Session sponsored by SERVIER
	Capsule: The debate still continues.
	HRT - COMBINED SEQUENTIAL OR INTERRUPTED R. Casper, Canada
	ESTROGEN - P.O. OR NASAL ADMINISTRATION F. Al-Azzawi, UK
	THE VALUE OF ALTERNATIVE THERAPIES L. Speroff, USA
	THE ROLE OF SUPPLEMENTAL ANDROGENS J. Studd, UK
	DHEA - A NEW CHALLENGE IN MENOPAUSAL HEALTH A. Genazzani, Italy
14:30-16:00	THE FUTURE OF GLOBAL ENDOMETRIAL ABLATION TECHNOLOGY, TODAY Chair: J. Cooper
	Session sponsored by NOVACEPT
	INTRODUCTION J.M. Cooper, USA
	HISTORY AND EVOLUTION OF ENDOMETRIAL ABLATION R. Gimpelson, USA
	NOVASURE GEA SYSTEM TECHNOLOGY OVERVIEW P. Laberge, Canada
	PROCEDURAL STEPS OF THE NOVASURE GEA SYSTEM R. Sabbah, Canada
	“LIVE” TELESURGERY OF THE NOVASURE GEA SYSTEM A. Gallinat, Germany
	WORLDWIDE CLINICAL RESULTS OF THE NOVASURE GEA SYSTEM J. Cooper, USA
	PANEL SESSION
16:30-18:30	MENOPAUSE AND HRT Chair: J. Studd, A. Genazzani, E. Peyer
	Capsule: Clinical issues are still unsolved.
	DOES HRT ENHANCE QUALITY OF LIFE? W. Utian, USA
	RISK OF BREAST CANCER AND HRT. HOW STRONG IS THE EVIDENCE? L. Speroff, USA
	HRT AND VENOUS THROMBOSIS: IS THERE CAUSE FOR CONCERN? M. Whitehead, UK
	CRITICAL EVALUATION OF RECENT STUDIES ON ISCHEMIC HEART DISEASE L. Speroff, USA
08:30-10:00	PREMATURITY Chair: R. Lamont, I. Blickstein, S. Arulkumaran	HALL C
	Capsule: The debate continues. Can we decrease mortality and morbidity?
	THE SPECTRUM OF PRETERM BIRTH G.C. Di Renzo, Italy
	CAN WE ESTABLISH UNIVERSAL CRITERIA FOR THE LOWER LIMIT OF VIABILITY? M. Carrapato, Portugal
	THE CONTRIBUTION OF MULTIPLE BIRTH ON PREMATURITY I. Blickstein, Israel
	STEROIDS - WHEN TO START, REPEAT OR NOT, UNTIL WHEN? M. Hannah, Canada
	CS OR VAGINAL DELIVERY OF EXTREME PREMATURE BABIES N. Fisk, UK
10:30-12:30	CESAREAN SECTION - MODE OF DELIVERY Chair: R. Paul, M. Hannah, S. Uzan
	Capsule: Should we have a strategy to minimize cesarean deliveries?
	CESAREAN SECTION FOR THE OLD PRIMIPARA A. Calder, UK
	CESAREAN SECTION UPON REQUEST - WOMEN'S RIGHTS.  N. Fisk, UK
	IS THERE A PLACE FOR THE VACUUM AND FORCEPS IN MODERN OBSTETRICS? R. Lamont, UK
	VAGINAL DELIVERY FOLLOWING CS ONE OR MORE  S. Arulkumaran, UK
	IS THERE AN OPTIMAL RATE OF CS? D. Farine, Canada
	SHOULD ALL BREECH BE DELIVERED BY CS - ROLE OF EXTERNAL VERSION M. Hannah, Canada
14:30-16:00	Session sponsored by FERRING PHARMACEUTICALS
	MANAGEMENT OF PRETERM LABOUR: THE WAY FORWARD Chair: D. Cabrol, N. Fisk
	CHAIRMAN'S INTRODUCTION
	MANAGEMENT OF PRETERM LABOUR AND PRETERM BIRTH I. Ingemarsson, Sweden
	TRACTOCILE ONE YEAR ON - HOW HAS IT CHANGED THE MANAGEMENT OF PRETERM LABOUR? R. Lamont, UK
	CLINICAL EXPERIENCE WITH TRACTOCILE P. Husslein, Austria
	DISCUSSION AND Q & A
	SUMMARY FROM THE CHAIRMAN
16:30-18:30	SECOND TRIMESTER MISCARRIAGE - DIAGNOSIS OF CERVICAL INCOMPETENCE Chair: B. Arabin, E. Shalev, J. Blankstein
	Capsule: Late abortion is mainly due to anatomical and mechanical problems.
	DIAGNOSIS OF CERVICAL INCOMPETENCE.  K. Nicolaides, UK
	CIRCLING OF CX - IS THERE ANY EVIDENCE THAT SHOWS BENEFITS OF CERCLAGE IN SINGLE AND TWINS? R. Lamont, UK
	CERVICAL FUNNELING - THE FALSE POSITIVE AND FALSE NEGATIVE OBSERVATIONS B. Arabin, The Netherlands
	UTERINE ANOMALIES - WHEN TO TREAT? WHEN TO CIRCLE? E. Shalev, Israel
	THE ROLE FOR EMERGENCY CERCLAGE - WHEN, UNTIL WHICH WEEK? K. Nicolaides, UK

top

	[Home Page] [Committees][Welcome Note] [Sponsors][Congress Program][Preliminary Timetable][General Information]   [Abstract Submission][Travel & Accommodation] [Request for Information][Registration Accommodation &Tours Form] [Previous Congress 1999][1999 Book of Proceedings]

Designed by